fda compounding semaglutide crackdown news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA ignites new fight over
Description
If prescribed by your DrWell provider, your prescription will be dispensed from a state-licensed third-party compounding pharmacy
While primarily designed to assess renal outcomes, the trial also demonstrated significant cardiovascular benefits
Dehydration worsens side effects, particularly nausea, fatigue, and constipation
A personal branding website for Hunter Williams, a biohacking educator and podca.
It automatically adds timestamps to entries and links them to your injection schedule
A call placed to the clinic was not returned
